Deciphering the COVID‐19 cytokine storm: systematic review and meta‐analysis R Mulchandani, T Lyngdoh, AK Kakkar European journal of clinical investigation 51 (1), e13429, 2021 | 244 | 2021 |
Drug treatment of obesity: current status and future prospects AK Kakkar, N Dahiya European Journal of Internal Medicine 26 (2), 89-94, 2015 | 158 | 2015 |
Bedaquiline for the treatment of resistant tuberculosis: promises and pitfalls AK Kakkar, N Dahiya Tuberculosis 94 (4), 357-362, 2014 | 146 | 2014 |
A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction … D Chopra, HS Rehan, P Mehra, AK Kakkar International journal of oral and maxillofacial surgery 38 (4), 350-355, 2009 | 117 | 2009 |
Physician's guide to pharmacovigilance: terminology and causality assessment HS Rehan, D Chopra, AK Kakkar European journal of internal medicine 20 (1), 3-8, 2009 | 116 | 2009 |
Management of Parkinson׳ s disease: Current and future pharmacotherapy AK Kakkar, N Dahiya European journal of pharmacology 750, 74-81, 2015 | 114 | 2015 |
Antimicrobial stewardship programs in resource constrained environments: understanding and addressing the need of the systems AK Kakkar, N Shafiq, G Singh, P Ray, V Gautam, R Agarwal, ... Frontiers in Public Health 8, 140, 2020 | 80 | 2020 |
Pattern of surgical antibiotic prophylaxis in a tertiary care teaching hospital in India HS Rehan, AK Kakkar, S Goel International journal of infection control 6 (2), 2010 | 69 | 2010 |
The evolving drug development landscape: from blockbusters to niche busters in the orphan drug space A Kumar Kakkar, N Dahiya Drug Development Research 75 (4), 231-234, 2014 | 65 | 2014 |
A comparative evaluation of sealing ability of new MTA based sealers with conventional resin based sealer: An in-vitro study L Ahuja, P Jasuja, KG Verma, S Juneja, A Mathur, R Walia, A Kakkar, ... Journal of clinical and diagnostic research: JCDR 10 (7), ZC76, 2016 | 46 | 2016 |
Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease H Singh, N Grewal, E Arora, H Kumar, AK Kakkar Journal of Natural Science, Biology, and Medicine 7 (1), 4, 2016 | 44 | 2016 |
Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study AK Kakkar, HS Rehan, KES Unni, NK Gupta, D Chopra, D Kataria European Psychiatry 24 (3), 178-182, 2009 | 43 | 2009 |
Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions R Mulchandani, AK Kakkar International Journal of Risk & Safety in Medicine 30 (1), 33-44, 2019 | 42 | 2019 |
Effect of lamotrigine, levetiracetam & topiramate on neurobehavioural parameters & oxidative stress in comparison with valproate in rats SC Sarangi, AK Kakkar, R Kumar, YK Gupta Indian Journal of Medical Research 144 (1), 104-111, 2016 | 38 | 2016 |
Evaluation of factors influencing distance stereoacuity on Frisby–Davis Distance Test (FD2) in intermittent exotropia R Saxena, A Kakkar, V Menon, P Sharma, S Phuljhele British journal of ophthalmology 95 (8), 1098-1101, 2011 | 36 | 2011 |
Repurposing minocycline for COVID-19 management: mechanisms, opportunities, and challenges H Singh, AK Kakkar, P Chauhan Expert Review of Anti-Infective Therapy 18 (10), 997-1003, 2020 | 29 | 2020 |
Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead H Singh, P Chauhan, AK Kakkar European Journal of Pharmacology 890, 173717, 2021 | 28 | 2021 |
Causality assessment of spontaneously reported adverse drug events: Comparison of WHO-UMC criteria and Naranjo probability scale HS Rehan, D Chopra, AK Kakkar International Journal of Risk & Safety in Medicine 19 (4), 223-227, 2007 | 26 | 2007 |
Effect of antiepileptic therapy on trace elements status in Indian population in a tertiary care hospital from northern India: a cross sectional study SC Sarangi, M Tripathi, AK Kakkar, YK Gupta Epilepsy research 108 (5), 917-927, 2014 | 25 | 2014 |
Statin use and safety concerns: an overview of the past, present, and the future R Mulchandani, T Lyngdoh, AK Kakkar Expert Opinion on Drug Safety 19 (8), 1011-1024, 2020 | 24 | 2020 |